Artificial intelligence: Deep learning in oncological radiomics and challenges of interpretability and data harmonization.

Journal: Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)
Published Date:

Abstract

Over the last decade there has been an extensive evolution in the Artificial Intelligence (AI) field. Modern radiation oncology is based on the exploitation of advanced computational methods aiming to personalization and high diagnostic and therapeutic precision. The quantity of the available imaging data and the increased developments of Machine Learning (ML), particularly Deep Learning (DL), triggered the research on uncovering "hidden" biomarkers and quantitative features from anatomical and functional medical images. Deep Neural Networks (DNN) have achieved outstanding performance and broad implementation in image processing tasks. Lately, DNNs have been considered for radiomics and their potentials for explainable AI (XAI) may help classification and prediction in clinical practice. However, most of them are using limited datasets and lack generalized applicability. In this study we review the basics of radiomics feature extraction, DNNs in image analysis, and major interpretability methods that help enable explainable AI. Furthermore, we discuss the crucial requirement of multicenter recruitment of large datasets, increasing the biomarkers variability, so as to establish the potential clinical value of radiomics and the development of robust explainable AI models.

Authors

  • Panagiotis Papadimitroulas
  • Lennart Brocki
    University of Warsaw - Institute of Informatics, Warsaw, Poland.
  • Neo Christopher Chung
    University of Warsaw - Institute of Informatics, Warsaw, Poland; University of California Los Angeles (UCLA) School of Medicine - Departments of Physiology and Medicine (Cardiology), USA.
  • Wistan Marchadour
    LaTIM, INSERM, UMR 1101, Univ Brest, Brest, France.
  • Franck Vermet
    LBMA, CNRS, UMR 6205, Univ Brest, Brest, France.
  • Laurent Gaubert
    LaTIM, INSERM, UMR 1101, Univ Brest, Brest, France; ENIB, Brest, France.
  • Vasilis Eleftheriadis
    Bioemission Technology Solutions - BIOEMTECH, Athens, Greece.
  • Dimitris Plachouris
    3DMI Research Group, Department of Medical Physics, University of Patras, Rion GR 265 04, Greece.
  • Dimitris Visvikis
    LaTIM, INSERM, UMR 1101, Brest 29609, France.
  • George C Kagadis
    Department of Medical Physics, School of Medicine, University of Patras, Rion GR 26504, Greece and Department of Imaging Physics, The University of  Texas MD Anderson Cancer Center, Houston, Texas 77030.
  • Mathieu Hatt
    LaTIM, INSERM, UMR 1101, Brest 29609, France.